191 related articles for article (PubMed ID: 38431645)
1. The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury.
Liu Y; Sun Z; Sun Q; Wang L; Wang C; Li Y; Ma C; Shi W; Zhang G; Dong Y; Zhang X; Cong B
Lipids Health Dis; 2024 Mar; 23(1):68. PubMed ID: 38431645
[TBL] [Abstract][Full Text] [Related]
2. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
3. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis.
Novgorodov SA; Chudakova DA; Wheeler BW; Bielawski J; Kindy MS; Obeid LM; Gudz TI
J Biol Chem; 2011 Feb; 286(6):4644-58. PubMed ID: 21148554
[TBL] [Abstract][Full Text] [Related]
4. Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.
Barron K; Ogretmen B; Krupenko N
J Nutr Biochem; 2021 Dec; 98():108832. PubMed ID: 34358645
[TBL] [Abstract][Full Text] [Related]
5. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.
Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ
Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360
[TBL] [Abstract][Full Text] [Related]
6. Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner.
Fekry B; Esmaeilniakooshkghazi A; Krupenko SA; Krupenko NI
PLoS One; 2016; 11(1):e0146618. PubMed ID: 26783755
[TBL] [Abstract][Full Text] [Related]
7. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network.
Senkal CE; Ponnusamy S; Manevich Y; Meyers-Needham M; Saddoughi SA; Mukhopadyay A; Dent P; Bielawski J; Ogretmen B
J Biol Chem; 2011 Dec; 286(49):42446-42458. PubMed ID: 22013072
[TBL] [Abstract][Full Text] [Related]
8. Folate stress induces apoptosis via p53-dependent de novo ceramide synthesis and up-regulation of ceramide synthase 6.
Hoeferlin LA; Fekry B; Ogretmen B; Krupenko SA; Krupenko NI
J Biol Chem; 2013 May; 288(18):12880-90. PubMed ID: 23519469
[TBL] [Abstract][Full Text] [Related]
9. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
[TBL] [Abstract][Full Text] [Related]
10. Danhe granule ameliorates nonalcoholic steatohepatitis and fibrosis in rats by inhibiting ceramide de novo synthesis related to CerS6 and CerK.
Zhu M; Jia Z; Yan X; Liu L; Fang C; Feng M; Dai Y; Zhang Y; Wu H; Huang B; Li Y; Liu J; Xiao H
J Ethnopharmacol; 2022 Sep; 295():115427. PubMed ID: 35654350
[TBL] [Abstract][Full Text] [Related]
11. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.
Senkal CE; Ponnusamy S; Bielawski J; Hannun YA; Ogretmen B
FASEB J; 2010 Jan; 24(1):296-308. PubMed ID: 19723703
[TBL] [Abstract][Full Text] [Related]
12. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
[TBL] [Abstract][Full Text] [Related]
13. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
14. By activating Fas/ceramide synthase 6/p38 kinase in lipid rafts, stichoposide D inhibits growth of leukemia xenografts.
Yun SH; Park ES; Shin SW; Ju MH; Han JY; Jeong JS; Kim SH; Stonik VA; Kwak JY; Park JI
Oncotarget; 2015 Sep; 6(29):27596-612. PubMed ID: 26318294
[TBL] [Abstract][Full Text] [Related]
15. Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.
Verlekar D; Wei SJ; Cho H; Yang S; Kang MH
Cell Death Dis; 2018 Sep; 9(9):925. PubMed ID: 30206207
[TBL] [Abstract][Full Text] [Related]
16. Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases.
Kim YR; Lee EJ; Shin KO; Kim MH; Pewzner-Jung Y; Lee YM; Park JW; Futerman AH; Park WJ
Exp Mol Med; 2019 Nov; 51(11):1-16. PubMed ID: 31676768
[TBL] [Abstract][Full Text] [Related]
17. CerS6 triggered by high glucose activating the TLR4/IKKβ pathway regulates ferroptosis of LO2 cells through mitochondrial oxidative stress.
Li D; Tian L; Nan P; Zhang J; Zheng Y; Jia X; Gong Y; Wu Z
Mol Cell Endocrinol; 2023 Jul; 572():111969. PubMed ID: 37230220
[TBL] [Abstract][Full Text] [Related]
18. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
19. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
[TBL] [Abstract][Full Text] [Related]
20. Adoptive Transfer of Ceramide Synthase 6 Deficient Splenocytes Reduces the Development of Colitis.
Scheffel MJ; Helke K; Lu P; Bowers JS; Ogretmen B; Garrett-Mayer E; Paulos CM; Voelkel-Johnson C
Sci Rep; 2017 Nov; 7(1):15552. PubMed ID: 29138469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
